Sign In

Dan Brennan

CEO/President at Alentia Therapeutics, Inc.

Dan Brennan is a seasoned biopharmaceutical leader with over 20 years of experience at reputable companies such as Catalyst Pharmaceuticals, Edge Therapeutics, Lundbeck, Abbott, and Eli Lilly.

Throughout his career, he has demonstrated expertise in leading large teams, managing multimillion-dollar businesses, and successfully launching multiple products.

Dan's unique background in social work, HR, and marketing has influenced his values-centered leadership style, contributing to his organizations' top reputation ratings and strong relationships with physician and patient communities.

His specialties include roles such as COO, CCO, CEO, GM, US President, with a focus on pharmaceutical and biopharmaceutical sectors, commercial operations, marketing, strategy, and sales.

He has a broad skill set in areas like new product planning, CNS, neurology, psychiatry, rare diseases, global launches, patient-centric approaches, strategic planning, human resources, and operational excellence.

Dan Brennan holds an MBA from Northwestern University - Kellogg School of Management and a BA from the University of Notre Dame in Arts and Letters Program for Administrators/Psychology. He previously served as the Chief Commercial Officer at Catalyst Pharmaceuticals, Inc.

Dan Brennan
Add to my network

Location

New York City Metropolitan Area